Atlas market file · Etf · United States
Nuveen Short-Term REIT ETFNURE
- Last close
- 31.65
- Change
- -1.83%
- 96-bar range
- 26.85 – 33.43
- As of
- 10 Aug 2026
Nuveen Short-Term REIT ETF is an exchange-traded fund listed as NURE on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-5.54% over the window).
Source rail: Yahoo Finance chart API (NURE). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for NURE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
NURE public profile
Exchange-traded fund. Nuveen Short-Term REIT ETF is connected to current market context, cited company sources and its retained research file.
Nuveen Short-Term REIT ETF trades as NURE on BATS. Nuveen Short-Term REIT ETF (NURE) has a latest verified close of 31.65, down 1.83%, dated 10 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. NURE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Nuveen Short-Term REIT ETF today
The Nuveen Short-Term REIT ETF (NURE) trades as a wrapper for 216 mortgage REITs, offering investors exposure to commercial real estate debt through a diversified basket. Unlike the glossy pitches of prime property ownership, NURE holds a portfolio dominated by lenders like Starwood Property Trust and Chimera Investment Corp, focusing on the less glamorous-but no less critical-business of financing real estate (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/nure).
NURE’s mandate is to provide short-term income from mortgage REITs, which it achieves through a passive index-tracking approach. The fund’s top holdings account for a significant portion of its $1.2 billion in assets under management, with a concentration that belies its ‘diversified’ marketing. The 0.45% expense ratio is higher than some competitors, but it’s a small price for those who prefer the convenience of a managed wrapper over direct investment (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=NURE).
The fund’s performance is tied to the FTSE Nareit Short-Term REIT Index, which tracks the short-term mortgage REIT sector. While the index provides a benchmark, NURE’s trading volume remains relatively low, averaging around 100,000 shares per day. This liquidity profile means it’s more suited to long-term investors than traders looking for quick exits (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/).
NURE’s chart on TradingView shows a steady but unremarkable performance, reflecting the underlying stability of its mortgage REIT holdings. The fund’s dividends are a key draw, but they come with the usual caveats of income-focused investments: sensitivity to interest rates and the health of the real estate market. The fund’s passive management means it won’t relative strength its index, but it also won’t lag due to active management fees (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/nure).
What remains unproven is whether NURE’s short-term focus can weather a prolonged downturn in commercial real estate. The fund’s holdings are heavily weighted towards mortgage lenders, which could face pressure if property values decline. With no earnings or revenue data to parse, the source requires readers to rely on the fund’s historical performance and the stability of its underlying assets. The next key development will be the fund’s ability to maintain its dividend yield in a rising interest rate environment (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=NURE).
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
NURE technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on NURE
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep NURE research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
NURE FAQ
What is Nuveen Short-Term REIT ETF (NURE)?Nuveen Short-Term REIT ETF (NURE) has a latest verified close of 31.65, down 1.83%, dated 10 Aug 2026. Use this page to check the price chart, company context,...
Nuveen Short-Term REIT ETF (NURE) has a latest verified close of 31.65, down 1.83%, dated 10 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for NURE?Nuveen Short-Term REIT ETF (NURE) has a latest verified close of 31.65, down 1.83%, dated 10 Aug 2026. It brings the latest available chart, company context, cited...
Nuveen Short-Term REIT ETF (NURE) has a latest verified close of 31.65, down 1.83%, dated 10 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. NURE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the NURE page updated?The NURE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The NURE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for NURE?The NURE file starts with Nasdaq Trader and TradingView BATS:NURE. The page separates verified market context from company evidence and shows open evidence gaps instead...
The NURE file starts with Nasdaq Trader and TradingView BATS:NURE. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on NURE?Yes. The workstation can open NURE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open NURE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this NURE page investment advice?No. The NURE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The NURE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
NURE
Etf · evidence first